Savill Corrine
- SEC CIK
- 0001837524
No open-market purchases or sales filed in the past year.
Current role at each company
- CGEM Cullinan Therapeutics, Inc.Chief Business Officeras of Feb 19, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Savill Corrine as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2024 (view filing) | Feb 1 | 1 day | Savill CorrineChief Business Officer | SSale | −40.0K | $16.18 | −$647.2K | −19.4%166.0K after | 10b5-1 |
| Jan 30, 2024 (view filing) | Jan 29 | 1 day | Savill CorrineChief Business Officer | SSale | −40.0K | $14.09 | −$563.6K | −19.4%166.0K after | 10b5-1 |
| Jan 24, 2024 (view filing) | Jan 22-23 | 2 days | Savill CorrineChief Business Officer | SSale | −40.0K | $12.31 | −$492.5K | −19.4%166.0K after | 3 lots10b5-1 |
| Jul 21, 2022 (view filing) | Jul 18-19 | 3 daysLate | Savill CorrineActing Chief Business Officer | SSale | −20.0K | $15.18 | −$303.6K | −11.8%149.6K after | 2 lots |
| Jul 12, 2022 (view filing) | Jul 11 | 1 day | Savill CorrineActing Chief Business Officer | SSale | −40.0K | $13.33 | −$533.3K | −19.1%169.6K after | 2 lots |